MedTrace Logo

Genetic and Environmental Characteristics of Primary Pulmonary Hypertension

NCT00091546 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2016-02-02

No results posted yet for this study

Summary

The goal of this study is to identify the modifying genes and environmental features that regulate the clinical expression of mutations in bone morphogenetic protein receptor 2 (BMPR2); to develop the understanding of how BMPR2 mutations result in disease; and to identify the undiscovered genetic mutations that cause primary pulmonary hypertension (PPH).

Conditions

  • Lung Diseases
  • Hypertension, Pulmonary

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • James Loyd · Vanderbilt University Medical Center

Eligibility

Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-08-31
Primary Completion
2009-07-31
Completion
2009-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00091546 on ClinicalTrials.gov